1. Home
  2. PHIO vs XTIA Comparison

PHIO vs XTIA Comparison

Compare PHIO & XTIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHIO
  • XTIA
  • Stock Information
  • Founded
  • PHIO 2011
  • XTIA 1999
  • Country
  • PHIO United States
  • XTIA United States
  • Employees
  • PHIO N/A
  • XTIA N/A
  • Industry
  • PHIO Biotechnology: Pharmaceutical Preparations
  • XTIA
  • Sector
  • PHIO Health Care
  • XTIA
  • Exchange
  • PHIO Nasdaq
  • XTIA NYSE
  • Market Cap
  • PHIO 8.6M
  • XTIA 7.5M
  • IPO Year
  • PHIO N/A
  • XTIA N/A
  • Fundamental
  • Price
  • PHIO $2.00
  • XTIA $1.68
  • Analyst Decision
  • PHIO Strong Buy
  • XTIA
  • Analyst Count
  • PHIO 1
  • XTIA 0
  • Target Price
  • PHIO $4.00
  • XTIA N/A
  • AVG Volume (30 Days)
  • PHIO 875.3K
  • XTIA 755.4K
  • Earning Date
  • PHIO 05-15-2025
  • XTIA 05-19-2025
  • Dividend Yield
  • PHIO N/A
  • XTIA N/A
  • EPS Growth
  • PHIO N/A
  • XTIA N/A
  • EPS
  • PHIO N/A
  • XTIA N/A
  • Revenue
  • PHIO N/A
  • XTIA $3,466,000.00
  • Revenue This Year
  • PHIO N/A
  • XTIA $59.74
  • Revenue Next Year
  • PHIO N/A
  • XTIA N/A
  • P/E Ratio
  • PHIO N/A
  • XTIA N/A
  • Revenue Growth
  • PHIO N/A
  • XTIA 1475.45
  • 52 Week Low
  • PHIO $0.97
  • XTIA $0.96
  • 52 Week High
  • PHIO $9.79
  • XTIA $507.50
  • Technical
  • Relative Strength Index (RSI)
  • PHIO 54.98
  • XTIA 53.24
  • Support Level
  • PHIO $1.71
  • XTIA $1.41
  • Resistance Level
  • PHIO $2.08
  • XTIA $2.07
  • Average True Range (ATR)
  • PHIO 0.13
  • XTIA 0.23
  • MACD
  • PHIO 0.01
  • XTIA 0.06
  • Stochastic Oscillator
  • PHIO 76.32
  • XTIA 50.63

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

About XTIA XTI AEROSPACE

XTI Aerospace Inc is an aircraft development company. It also provides real-time location systems (RTLS) for the industrial sector. The company is developing a vertical takeoff and landing (VTOL) airplane that is designed to take off and land like a helicopter and cruise like a fixed-wing business airplane. Its initial configuration, the TriFan 600 airplane, will be one of the first civilian fixed-wing VTOL airplane that offers the speed and comfort of a business airplane and the range and versatility of VTOL for a wide range of customer applications, including private aviation for business and high net worth individuals, emergency medical services, and regional charter air travel. The company operates in two reportable segments: Industrial IoT and Commercial Aviation.

Share on Social Networks: